U. Sonnenborn

3.8k total citations
37 papers, 3.0k citations indexed

About

U. Sonnenborn is a scholar working on Endocrinology, Food Science and Molecular Biology. According to data from OpenAlex, U. Sonnenborn has authored 37 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, 18 papers in Food Science and 10 papers in Molecular Biology. Recurrent topics in U. Sonnenborn's work include Escherichia coli research studies (20 papers), Probiotics and Fermented Foods (17 papers) and Gut microbiota and health (6 papers). U. Sonnenborn is often cited by papers focused on Escherichia coli research studies (20 papers), Probiotics and Fermented Foods (17 papers) and Gut microbiota and health (6 papers). U. Sonnenborn collaborates with scholars based in Germany, Czechia and France. U. Sonnenborn's co-authors include Jürgen P. Schulze, Corinne Enders, Christoph Cichon, M. Alexander Schmidt, Jörg Hacker, Simone Helms, Lubomir Grozdanov, Gerhard Gottschalk, Ulrich Dobrindt and Tobias A. Oelschlaeger and has published in prestigious journals such as Gastroenterology, Applied and Environmental Microbiology and FEBS Letters.

In The Last Decade

U. Sonnenborn

37 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Sonnenborn Germany 24 1.7k 1.2k 632 565 538 37 3.0k
Tobias A. Oelschlaeger Germany 33 1.6k 0.9× 1.1k 1.0× 933 1.5× 541 1.0× 544 1.0× 61 3.6k
Sean‐Paul Nuccio United States 22 1.6k 0.9× 1.2k 1.0× 816 1.3× 780 1.4× 422 0.8× 33 3.3k
Belgin Dogan United States 25 2.5k 1.4× 929 0.8× 638 1.0× 866 1.5× 819 1.5× 47 4.5k
Jean‐Marc Chatel France 33 1.8k 1.0× 1.3k 1.1× 212 0.3× 718 1.3× 434 0.8× 85 3.5k
Toru Tobe Japan 21 1.9k 1.1× 965 0.8× 1.3k 2.0× 1.0k 1.8× 771 1.4× 38 3.7k
Thierry Pédron France 27 1.6k 1.0× 504 0.4× 553 0.9× 620 1.1× 415 0.8× 58 3.1k
Marta Wlodarska Canada 13 1.8k 1.1× 697 0.6× 761 1.2× 1.0k 1.8× 318 0.6× 13 3.5k
Olivia L. Champion United Kingdom 19 1.3k 0.8× 762 0.7× 320 0.5× 836 1.5× 352 0.7× 28 2.6k
Biswa Choudhury United States 30 1.7k 1.0× 462 0.4× 255 0.4× 571 1.0× 485 0.9× 69 3.2k
Çağla Tükel United States 27 1.6k 0.9× 855 0.7× 571 0.9× 488 0.9× 307 0.6× 57 2.8k

Countries citing papers authored by U. Sonnenborn

Since Specialization
Citations

This map shows the geographic impact of U. Sonnenborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Sonnenborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Sonnenborn more than expected).

Fields of papers citing papers by U. Sonnenborn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Sonnenborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Sonnenborn. The network helps show where U. Sonnenborn may publish in the future.

Co-authorship network of co-authors of U. Sonnenborn

This figure shows the co-authorship network connecting the top 25 collaborators of U. Sonnenborn. A scholar is included among the top collaborators of U. Sonnenborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Sonnenborn. U. Sonnenborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sonnenborn, U.. (2016). Escherichia colistrain Nissle 1917—from bench to bedside and back: history of a specialEscherichia colistrain with probiotic properties. FEMS Microbiology Letters. 363(19). fnw212–fnw212. 202 indexed citations
2.
Šplı́chalová, Alla, Igor Šplı́chal, U. Sonnenborn, & V. Rada. (2014). A modified MacConkey agar for selective enumeration of necrotoxigenic E. coli O55 and probiotic E. coli Nissle 1917. Journal of Microbiological Methods. 104. 82–86. 5 indexed citations
3.
Hoffmeier, Klaus, Nicolas Krezdorn, Chunguang Liang, et al.. (2014). Complete genome sequence of the Gram-negative probiotic Escherichia coli strain Nissle 1917. Journal of Biotechnology. 187. 106–107. 66 indexed citations
4.
Rohde, Holger, et al.. (2013). Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. International Journal of Medical Microbiology. 303(1). 1–8. 48 indexed citations
5.
Cichon, Christoph, et al.. (2011). Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells. The International Journal of Biochemistry & Cell Biology. 44(2). 341–349. 41 indexed citations
6.
Schulze, Jürgen P. & U. Sonnenborn. (2009). Yeasts in the Gut. Deutsches Ärzteblatt international. 106(51-52). 837–42. 134 indexed citations
7.
Bar, Fatma M. Abdel, Uwe J. Roblick, H.‐P. Bruch, et al.. (2009). Cell‐free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterology & Motility. 21(5). 559–559. 91 indexed citations
8.
Remer, Katharina A., et al.. (2009). Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. International Journal of Medical Microbiology. 299(7). 467–478. 31 indexed citations
9.
Sonnenborn, U. & Jürgen P. Schulze. (2009). The non-pathogenicEscherichia colistrain Nissle 1917 – features of a versatile probiotic. Microbial Ecology in Health and Disease. 21(3-4). 1 indexed citations
10.
Paclik, Daniela, et al.. (2008). The probiotic Escherichia coli strain Nissle 1917 induces γδ T cell apoptosis via caspase- and FasL-dependent pathways. International Immunology. 20(7). 829–840. 38 indexed citations
11.
Huff, G.R., W.E. Huff, Corinne Enders, et al.. (2006). Oral treatment with the probiotic Escherichia coli Nissle 1917 improves body weight and modulates the stress response of poultry in respiratory challenges with avian pathogenic E. coli.. 4 indexed citations
13.
Liebregts, Tobias, Adam Białas, Spencer B. Jones, et al.. (2005). Effect of E. coli Nissle 1917 on post‐inflammatory visceral sensory function in a rat model. Neurogastroenterology & Motility. 17(3). 410–414. 32 indexed citations
14.
Oswald, Sibylle, et al.. (2004). The probioticEscherichia colistrain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunology & Medical Microbiology. 40(3). 223–229. 169 indexed citations
15.
Blum–Oehler, Gabriele, Sibylle Oswald, U. Sonnenborn, et al.. (2003). Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples. Research in Microbiology. 154(1). 59–66. 71 indexed citations
16.
Cukrowská, Božena, et al.. (2002). Specific Proliferative and Antibody Responses of Premature Infants to Intestinal Colonization with Nonpathogenic Probiotic E. coli Strain Nissle 1917. Scandinavian Journal of Immunology. 55(2). 204–209. 87 indexed citations
17.
Grozdanov, Lubomir, Ulrich Zähringer, Gabriele Blum–Oehler, et al.. (2002). A Single Nucleotide Exchange in the wzy Gene Is Responsible for the Semirough O6 Lipopolysaccharide Phenotype and Serum Sensitivity of Escherichia coli Strain Nissle 1917. Journal of Bacteriology. 184(21). 5912–5925. 142 indexed citations
20.
Sonnenborn, U. & Wolf‐H. Kunau. (1982). Purification and properties of the fatty acid synthetase complex from the marine dinoflagellate, Crypthecodinium cohnii. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 712(3). 523–534. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026